Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175682 | SCV000227217 | uncertain significance | not provided | 2015-02-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000374205 | SCV000396198 | uncertain significance | Familial infantile myoclonic epilepsy | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Laboratory for Molecular Medicine, |
RCV000826047 | SCV000967540 | uncertain significance | not specified | 2018-09-06 | criteria provided, single submitter | clinical testing | The c.-4C>T variant in TBC1D24 has not been previously reported in individuals w ith hearing loss, DOOR syndrome, or epilepsy, but has been identified in 0.017% (3/17226) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). This variant has also been reported in ClinVa r (Variation ID 195133). This variant is located in the 5' untranslated region, and it is unknown whether it affects protein function. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: none. |